Surgalign Holdings, Inc. Common Stock
SRGA
SRGA was delisted on the 30th of June, 2023.
35 hedge funds and large institutions have $3.58M invested in Surgalign Holdings, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 3 closing their positions.
11% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 9
4% more capital invested
Capital invested by funds: $3.43M → $3.58M (+$153K)
3% less funds holding
Funds holding: 36 → 35 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$1.93M |
| 2 |
AWS
Atria Wealth Solutions
New York
|
+$351K |
| 3 |
Cerity Partners
New York
|
+$177K |
| 4 |
Jane Street
New York
|
+$49.4K |
| 5 |
KOC
Koss-Olinger Consulting
Gainesville,
Florida
|
+$33.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CLG
Cooperman Leon G
|
-$435K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$114K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$65.7K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$18.3K |
| 5 |
Renaissance Technologies
New York
|
-$17.8K |
SRGA Hedge Fund Activity: Q4 2022 in Review
35 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q4 2022, worth a combined $3.58M — up 4.5% from $3.43M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of SRGA and 2 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 10 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $1.93M. The largest seller was Cooperman Leon G, exiting entirely with an estimated $435K sold.
- 35 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q4 2022, down from 36 in Q3 2022.
- Funds reported $3.58M of Surgalign Holdings, Inc. Common Stock stock for Q4 2022, up 4.5% quarter-over-quarter.
- 2 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q4 2022 and 3 closed out, a net change of -1 holder.
- The largest Surgalign Holdings, Inc. Common Stock buyer in Q4 2022 was Armistice Capital, an estimated $1.93M added.
- The largest Surgalign Holdings, Inc. Common Stock seller in Q4 2022 was Cooperman Leon G, an estimated $435K sold.
Based on aggregated 13F filings for Q4 2022.